AIM ImmunoTech Inc. (AIM) Business News June 12, 2025, 12:30 UTC AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen® Full text
There are no comments here yet...